Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,043 public trials 2,030 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269

Conditions: B-Cell Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hemocentro-Unicamp Campinas, Brazil

Centro Medico Santa Isabel, Brazil

Centro Paulista de Oncologia São Paulo, Brazil

Santa Casa Medical School São Paulo, Brazil

View all 39 locations

View Trial Details

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

NCT00144092

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

View Trial Details

Completed

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

NCT00003195

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007

NCT01470924

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: Orebro University Hospital Örebro, Örebro County, Sweden

View Trial Details

Completed

Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration

NCT00570817

Conditions: Ependymoma, Glioma, Hematologic Diseases, +20 more
Locations: Aarhus University Hospital, Skejby Aarhus, Aarhus N, Denmark

View Trial Details

Completed

Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

NCT00078234

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations: Georgetown University Medical Center/Lombardi Cancer Center Washington D.C., District of Columbia, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Long Island Jewish Medical Center New Hyde Park, New York, United States

View Trial Details

Completed

A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00478777

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Medizinische Klinik und Poliklinik II der Charité Universitätsmedizin Berlin Campus Mitte Berlin, Germany

Poliklinik I, Hämatologie/ Onkologie, Universitätsklinikum Bonn Bonn, Germany

Johanniter-Krankenhaus Bonn Friedrich-Wilhelm-Stift gGmbH Bonn, Germany

Medizinische Klinik Städtisches Klinikum Braunschweig gGmbH Braunschweig, Germany

View all 48 locations

View Trial Details

Completed

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

NCT00784810

Conditions: Arthritis, Back Pain, Hemic and Lymphatic Diseases, +17 more
Locations: Coventry, United Kingdom

View Trial Details

Completed

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

NCT00452374

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: University of California-San Diego La Jolla, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

NCT00038623

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions